Drug Trial Radar · NCT02257983
Protective Effects of EPI-743 on Noise-Induced Hearing Loss
Last checked: Nov 20, 2026Latest source record: Nov 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
Oct 31, 2014
Primary completion
Nov 30, 2015
Study completion Feb 29, 2016
Sponsor
- Lead sponsor
- Edison Pharmaceuticals IncIndustry
- Sponsor type
- Industry
- First posted
- Oct 7, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 30 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.
Conditions
- Noise-induced Hearing Loss
Interventions
EPI-743Drug
EPI-743 (2 capsules 200 mg each) taken at a dose of 400 mg P.O. TID for 9 days with noise exposure for 4 hours on Day 8.
PlaceboDrug
2 Placebo capsules P.O. TID for 9 days with noise exposure for 4 hours on Day 8.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pure tone audiometryTime frame: 9 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Florida
Gainesville, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.